StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3017% above fair value
$9.00−0.08 (-0.88%)

Close on Nov 18, 2026Market cap $40.97MP/E –Yield –

Harvard Bioscience EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Harvard Bioscience's EV/EBITDA was 104.7× on Apr 30, 2024, against 88.8× a year earlier. Over the last 5 years it ranged from 27.2× to 963.6×, with a median of 104.9×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 2024104.7×−122.2
2023Dec 29, 2023226.9×+103.2
2022Apr 29, 2022123.7×+18.8
2021Dec 31, 2021104.9×−284.5
2020Apr 30, 2020389.4×+57.5
2019Dec 31, 2019331.9×−40.6
2016Jan 29, 2016372.5×−57.5
2015Dec 31, 2015430.0×+380.7
2014Dec 31, 201449.3×+30.8
2013Dec 31, 201318.6×+8.8
2012Dec 31, 20129.7×−1.6
2011Dec 30, 201111.3×−1.8
2010Dec 31, 201013.1×–

More Harvard Bioscience figures

See a number that looks wrong?